Contribution to the International AIDS Society Educational Fund Programme
Significant yet insufficient progress has been made in the HIV/AIDS response. The body of evidence is large and tools are available but they are not fast enough disseminated, contextualized and included into national policies and programmes. The Educational Fund addresses this by offering countries different tailor-made modules. Through Swiss support, the programme will increasingly embed HIV/AIDS into a broader health response.
Región/País | Tema | Período | Presupuesto |
---|---|---|---|
A nivel mundial |
Salud
Enfermedades de transmisión sexual inclusive el VIH/sida
Salud y derechos reproductivos Fortalecimiento del sistema sanitario |
01.11.2018
- 30.06.2021 |
CHF 747’000
|
- Otra organización suiza sin fines lucrativos
-
Sector según clasificación del comité de ayuda al desarrollo de la OCDE PROGRAMAS / POLÍTICAS SOBRE POBLACIÓN Y SALUD REPRODUCTIVA
PROGRAMAS / POLÍTICAS SOBRE POBLACIÓN Y SALUD REPRODUCTIVA
SALUD
Sub-Sector según clasificación del comité de ayuda al desarrollo de la OCDE Lucha contra ETS (enfermedades de transmisión sexual), incluido el VIH/SIDA
Atención salud reproductiva
Política sanitaria y gestión administrativa
Temas transversales El proyecto apoya también mejoras en la organización contraparte
Tipo de ayuda Contribución a proyectos y programas
Número de proyecto 7F10177
Contexto | Despite some success in addressing the AIDS epidemic, the risk of the epidemic to raise again is real, if action remains slow. Today, an estimated 37 Million people worldwide live with HIV. Just over half receive treatment. Many of those not receiving treatment don’t know their HIV status. Between 1996 and 2017, new HIV infections decreased by 47%. However, progress is stagnating, with 1.8 million new infections in 2017. Also, persistent HIV/AIDS related stigma and discrimination considerably hinders successful prevention, testing, care and treatment. |
Objetivos | Reduction of new HIV infections and AIDS-related deaths. |
Grupos destinarios |
Direct target group/s: Healthcare professionals, researchers, advocates, policy makers, civil society and development partners. Ultimate target group/s: Children and men and women vulnerable to and living with HIV |
Efectos a medio plazo | HIV-related public strategies and programmes, clinical practice and social support for people living with and vulnerable to HIV are revised based on the latest scientific evidence and implemented. |
Resultados |
Resultados previstos: Skills, knowledge and professional networks of the programme alumni (clinicians, HIV service providers, policy makers, HIV advocates, programme managers, implementers, scientists, journalists and other stakeholders in the HIV response) are enhanced. Resultados de las fases anteriores: The IAS’ Educational Fund Programme disseminates and contextualizes up to date evidence and tools so as to inform policies and programmes. The Programme has so far been implemented in Nigeria, Senegal, Morocco, Brazil, Kenya, Argentina, Thailand, Côte d’Ivoire, Mexico, India and Ukraine and directly reached 2,250 stakeholders in the field of HIV/AIDS through the convening (healthcare professionals, researchers, advocates, policy makers and development partners). Several meetings resulted in formal policy recommendations and calls to action to national governments (Morocco, Kenya, Mexico, Argentina). Results depend much on a given context. Examples of results include but are not limited to increased involvement of target groups (e.g. adolescents) in designing programmes and service delivery; revised curriculum content for training of nurses; mentorship of clinical workers introduced about recent advances in HIV treatment and rolling out test and treat approaches; guidelines and programmes for new approaches (e.g. Post-Exposure Prophylaxis) developed. |
Dirección / Officina Federal responsable |
COSUDE |
Crédito |
Cooperación al desarrollo |
Contrapartes del proyecto |
Contraparte del contrato Organización suiza sin fines de lucro Otras contrapartes National partners involved in the HIV/Aids response and health more broadly (national governments, civil society, etc.) |
Coordinación con otros proyectos y actores | Pharmaceutical companies (ViiV Healthcare, Gilead Sciences),Joint UN Programme on HIV/AIDS (UNAIDS), Global Fund against AIDS, Tuberculosis and Malaria (GF) |
Presupuesto | Fase en curso Presupuesto suizo CHF 747’000 Presupuesto actual suizo ya emitido CHF 737’300 |
Fases del proyecto |
Fase 1 01.11.2018 - 30.06.2021 (Completed) |